InVivo Therapeutics Holdings Corporation(NASDAQ : NVIV)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
CELG | Celgene Corporation | -1.94% | 88.65 | 1.3% | $803.98m | |
AMGN | Amgen Inc. | -0.76% | 185.50 | 1.2% | $628.99m | |
GILD | Gilead Sciences, Inc. | -2.14% | 65.55 | 0.9% | $482.29m | |
BIIB | Biogen Inc. | -4.17% | 321.17 | 1.3% | $427.44m | |
ILMN | Illumina, Inc. | -1.77% | 296.88 | 3.5% | $311.35m | |
REGN | Regeneron Pharmaceuticals, Inc. | -0.92% | 418.62 | 2.6% | $290.18m | |
VRTX | Vertex Pharmaceuticals Incorporated | -2.55% | 183.06 | 1.9% | $253.58m | |
ALXN | Alexion Pharmaceuticals, Inc. | -1.76% | 127.55 | 2.0% | $219.68m | |
SRPT | Sarepta Therapeutics, Inc. | -2.87% | 136.54 | 15.4% | $152.33m | |
A | Agilent Technologies, Inc. | -0.83% | 77.91 | 1.6% | $150.84m | |
EXAS | Exact Sciences Corporation | -0.42% | 83.28 | 25.3% | $132.28m | |
INCY | Incyte Corporation | -0.49% | 83.33 | 2.5% | $111.93m | |
ARRY | Array BioPharma Inc. | -1.99% | 22.71 | 8.2% | $108.01m | |
EXEL | Exelixis, Inc. | -0.09% | 21.22 | 6.4% | $82.07m | |
NBIX | Neurocrine Biosciences, Inc. | -2.58% | 77.31 | 5.1% | $77.22m |
Company Profile
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of SCIs. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in 2005 and is headquartered in Cambridge, MA.